
zzso principles were used to determine zzso doses for zzso cancer patients on empirical zzso regimens, and zzso was used to determine the effect of this treatment on auditory zzso Patients received zzso 300 zzso plus zzso or zzso 8 zzso plus zzso in a blinded zzso zzso doses were calculated to achieve a peak serum concentration (one hour after zzso of approximately 25 zzso and a trough concentration of approximately 8 zzso zzso zzso was conducted, and follow-up zzso was done on completion of the zzso zzso A decrease of greater than or equal to 20 zzso at any frequency in one or both ears was considered indicative of zzso Of 201 patients on the empirical zzso zzso 55 had courses of treatment that could be zzso zzso not attributable to any other drug or disease process occurred in 10 zzso There were no significant differences related to age, weight, daily dose, or total dose between patients who developed zzso and those who did zzso Peak and trough zzso zzso were not significantly different between zzso More women than men developed zzso zzso of therapy for the zzso group was longer, and there was a trend for those with abnormal initial zzso to develop further evidence of zzso The significant risk factor for auditory toxicity was the combination of duration of zzso therapy and total dose per zzso zzso calculated doses of zzso did not result in a higher zzso of auditory toxicity than reported in previous zzso 

